In individuals with specific malignancies, including as head and neck squamous cell carcinoma and lung adenocarcinoma, a combination of inhibitors has been shown to reduce tumour growth and prevent relapse. Their findings encourage the creation of novel therapy modalities that specifically t
Studies suggested that persons who take proton pump inhibitors for at least four and a half years may be at an increased risk of dementia compared to those who do not take these drugs, according to an article in Neurology, the official journal of the American Academy of Neurology. This resea
According to new research, people who take proton pump inhibitors for four and a half years or more may have a higher risk of dementia than people who do not take these medications. This study does not establish that acid reflux medications cause dementia; rather, it demonstrates a correlati
Researchers at Stanford Medicine have described a novel subtype of depression known as the cognitive biotype, which affects 27 per cent of people with depression but is unresponsive to treatment with antidepressants that are frequently administered.
Because the disease is becoming increasingly resistant to existing medications, a group of UCF researchers is attempting to use cancer pharmaceuticals to accelerate the development of new, life-saving malaria treatments. The study's findings were published in the journal ACS Infectious Disea
A group of UCF researchers are looking to use cancer pharmaceuticals to hasten the development of fresh, life-saving malaria treatments because the disease is getting more and more resistant to existing medications.
Breast cancer medicines known as aromatase inhibitors may diminish the benefit of weight loss therapies, according to a new study presented at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.
Researchers found cancer cells can adapt to new drugs called CDK2 inhibitors in 1-2 hours, but adding a second drug squelches the workaround. The study was published in Journal, 'Cell.'
According to a new study presented at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill., breast cancer treatments known as aromatase inhibitors may reduce the effect of weight reduction therapies.
Cisplatin is commonly used as a chemotherapeutic drug in the treatment of many solid tumours, including bladder, ovarian, and esophageal tumours. However, when it is metabolised by an enzyme called "cysteine conjugate beta-lyase 1 (CCBL1)," it is transformed to "thiol-cisplatin," a highly ac
The disulfidptosis form of cell death, which was previously unknown, is described in a study from the University of Texas MD Anderson Cancer Center that was published today in Nature Cell Biology. This finding may pave the way for fresh cancer treatment options.